Back to search

Article

Pro108Ser mutant of SARS-CoV-2 3CL <sup>pro</sup> Reduces the Enzymatic Activity and Ameliorates COVID-19 Severity in Japan

2020-12-30

Abstract excerpt

Background: It is well known that SARS-CoV-2 genome accumulates point mutations constantly. However, whether non-synonymous mutations affect COVID-19 severity through altering viral protein function remains unknown.<br><br>Methods: We performed SARS-CoV-2 genome sequencing in 90 patients with COVID-19 admitted at Keio University Hospital in Tokyo Metropolitan area between March and August 2020. Viral haplotypes we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ff960808-b03d-5419-b731-6973a98a265b
DOI
10.2139/ssrn.3757398
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pro108Ser mutant of SARS-CoV-2 3CL <sup>pro</sup> Reduces the Enzymatic Activity and Ameliorates COVID-19 Severity in JapanDOI 10.2139/ssrn.3757398
Select a neighboring publication to make it the new centre.